We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNG icon
7326
Scorpio Tankers
STNG
$3.87B
$3K ﹤0.01%
100
-20
-17% -$727
THM
7327
International Tower Hill Mines
THM
$458M
$3K ﹤0.01%
6,144
-1,865
-23% -$1.01K
PHLT
7328
DELISTED
Performant Healthcare Inc
PHLT
$3K ﹤0.01%
1,419
-2,275
-62% -$4.32K
ISZE
7329
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
$3K ﹤0.01%
+100
New +$2.69K
VBIV
7330
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$3K ﹤0.01%
25
-234
-90% -$28.1K
TTOO
7331
DELISTED
T2 Biosystems, Inc
TTOO
0
GGE
7332
DELISTED
Green Giant Inc. Common Stock
GGE
$3K ﹤0.01%
1,037
+181
+21% +$527
TKAT
7333
DELISTED
Takung Art Co., Ltd.
TKAT
$3K ﹤0.01%
1,451
-1,140
-44% -$3.93K
BNSO
7334
DELISTED
Bonso Electronic International
BNSO
$3K ﹤0.01%
1,168
-3,769
-76% -$9.16K
APTO
7335
DELISTED
Aptose Biosciences, Inc.
APTO
$3K ﹤0.01%
5
+2
+67% +$1.34K
SRNE
7336
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3K ﹤0.01%
1,500
-2,043
-58% -$3.75K
OTIC
7337
DELISTED
Otonomy, Inc.
OTIC
$3K ﹤0.01%
869
-897
-51% -$12.1K
TMBR
7338
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$3K ﹤0.01%
+1
New +$5.14K
AMPE
7339
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
19
+7
+58% +$1.11K
HMG
7340
DELISTED
HMG / Courtland Properties Inc
HMG
$3K ﹤0.01%
+332
New +$3.72K
OTEL
7341
DELISTED
Otelco, Inc. Class A
OTEL
$3K ﹤0.01%
352
+170
+93% +$1.43K
DL
7342
DELISTED
China Distance Education Holdings Limited
DL
$3K ﹤0.01%
443
-786
-64% -$5.73K
FNJN
7343
DELISTED
Finjan Holdings, Inc.
FNJN
$3K ﹤0.01%
1,354
-102
-7% -$279
LVHE
7344
DELISTED
Legg Mason Emerging Markets Low Volatility High Dividend ETF
LVHE
$3K ﹤0.01%
101
+82
+432% +$2.25K
CASM
7345
DELISTED
CAS Medical Systems, Inc.
CASM
$3K ﹤0.01%
3,278
-8,786
-73% -$9K
CMTA
7346
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$3K ﹤0.01%
+158
New +$2.58K
ABCD
7347
DELISTED
Cambium Learning Group, Inc.
ABCD
$3K ﹤0.01%
456
-2,240
-83% -$12.1K
XRM
7348
DELISTED
Xerium Technologies Inc (new)
XRM
$3K ﹤0.01%
573
-3,070
-84% -$19.6K
HAHA
7349
DELISTED
CSOP China CSI 300 A-H Dynamic ETF
HAHA
$3K ﹤0.01%
+89
New +$2.76K
GHS
7350
DELISTED
REX Gold Hedged S&P 500 ETF
GHS
$3K ﹤0.01%
+80
New +$2.5K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.